Skip to main content

Table 3 Overlap R(A, B) between sets of genes marked as differentially expressed after pre-processing with different methods. p- and q-values for the significance of difference in expression between samples from the AML dataset with recurrent FLT3 mutation and samples without recurrent FLT3 mutation were calculated. The numbers on the diagonal represents the number of probe sets marked as differentially expressed after application of each method.

From: The effect of oligonucleotide microarray data pre-processing on the analysis of patient-cohort studies

  

MAS

dChip

RMA

GCRMA

SAM q-values

MAS

3185

   
 

dChip

0.68

2973

  
 

RMA

0.72

0.72

3649

 
 

GCRMA

0.73

0.70

0.86

3650

t-test p-values

MAS

458

   
 

dChip

0.66

354

  
 

RMA

0.68

0.70

419

 
 

GCRMA

0.69

0.71

0.83

472

Wilcoxon test p-values

MAS

337

   
 

dChip

0.72

295

  
 

RMA

0.75

0.79

322

 
 

GCRMA

0.75

0.79

0.87

344